Papers in BJC Reports
Page 5 · newest first
- Small extracellular vesicles in plasma carry luminal cytokines that remain undetectable by antibody-based assays in cancer patients and healthy donorsBJC Reports · 2024
- Germline sequencing in men with metastatic castration-resistant prostate cancer from the BARCODE2 study reveals a wide range of pathogenic variants in DNA repair genesBJC Reports · 2024
- Comparative efficacy of combined CTLA-4 and PD-1 blockade vs. PD-1 monotherapy in metastatic melanoma: a real-world studyBJC Reports · 2024
- Incidental finding of leukaemia in circulating tumour DNA— the importance of a molecular tumour boardBJC Reports · 2024
- Protein prognostic biomarkers in stage II colorectal cancer: implications for post-operative managementBJC Reports · 2024
- Spatial functional mapping of hypoxia inducible factor heterodimerisation and immune checkpoint regulators in clear cell renal cell carcinomaBJC Reports · 2024
- PTEN pathogenic variants are associated with poor prognosis in patients with advanced soft tissue sarcomaBJC Reports · 2024
- Results and lessons learnt from the WISTERIA phase I trial combining AZD1775 with cisplatin pre- or post-operatively in head and neck cancerBJC Reports · 2024
- Impact of underlying liver disease on unresectable hepatocellular carcinoma treated with immune checkpoint inhibitorsBJC Reports · 2024
- Expression of transglutaminase-2 (TGM2) in the prognosis of female invasive breast cancerBJC Reports · 2024
- Artificial intelligence-powered discovery of small molecules inhibiting CTLA-4 in cancerBJC Reports · 2024
- A Phase 2 study of nivolumab in combination with modified FOLFIRINOX for metastatic pancreatic cancerBJC Reports · 2024
- Patterns of referrals to regional clinical genetics services for women potentially at above-population level risk of breast cancerBJC Reports · 2024
- Metformin may improve the outcome of patients with colorectal cancer and type 2 diabetes mellitus partly through effects on neutrophil extracellular trapsBJC Reports · 2023
- Identification of cancer driver mutations in liquid-based cytology samples for the screening of endometrial diseasesBJC Reports · 2023
- Direct administration of human leucocyte antigen (dHLA) molecules into tumour sites: proposal for a new immunotherapy for cancerBJC Reports · 2023
- Developing a risk prediction tool for lung cancer in Kent and Medway, England: cohort study using linked dataBJC Reports · 2023
- An apparent quandary: adoption of polygenics and gene panels for personalised breast cancer risk stratificationBJC Reports · 2023
- Best analgesia control in pancreatic adenocarcinoma study: justification and feasibility of a randomised trial of early EUS-CPN versus standard care—a prospective observational study (The BAC-PAC study)BJC Reports · 2023
- Prevalence of the human papillomavirus (HPV) types among cervical dysplasia women attending a gynaecological clinic in SwedenBJC Reports · 2023
- Gut microbiome and nutrition-related predictors of response to immunotherapy in cancer: making sense of the puzzleBJC Reports · 2023
- C-reactive protein kinetics as a predictive marker for long-term outcome of immune checkpoint inhibitors in oesophagogastric cancerBJC Reports · 2023
- The role of virtual consultations in cancer genetics: challenges and opportunities introduced by the COVID-19 pandemicBJC Reports · 2023
- Radiomics and outcome prediction to antiangiogenic treatment in advanced gastroenteropancreatic neuroendocrine tumours: findings from the phase II TALENT trialBJC Reports · 2023
- Lung cancer in never smokers (LCINS): development of a UK national research strategyBJC Reports · 2023
- The amino-acid stress sensing eIF2α kinase GCN2 is a survival biomarker for malignant mesotheliomaBJC Reports · 2023
- Relationship between 233 colorectal cancer risk loci and survival in 1926 patients with advanced diseaseBJC Reports · 2023
- UK recommendations for the management of transgender and gender-diverse patients with inherited cancer risksBJC Reports · 2023